Page 17 - Labatt BTRC Annual Report 2020-2021

W
NanoString nCounter Vantage 3D platform-based complementary diagnostic tests for precision medicine in pediatric cancer. Genome Canada
Investigating the role of oncohistones in cancer development. Canadian Cancer Society Research Institute
Molecular based approach for discovery and improved outcome for children and young adults with low grade glioma. Canadian Institutes of Health Research
Defining the role of the histone 3 (H3.3G34R) mutation in the pathogenesis of pediatric high- grade astrocytoma. Canadian Institutes of Health Research
Dr. Annie Huang
Immunomodulation to treat poor-prognosis pediatric brain tumors. Stand Up To Cancer
Molecular basis of clinical heterogeneity in rhabdoid brain tumours. Canadian Institutes of Health Research
Institute advancing biology-based therapies for rhabdoid brain tumors. Canadian Cancer Society Research
Delineating transforming pathways in primitive neuro-ectodermal brain tumors. Canadian Institutes of Health Research
Biology informed therapeutics for embryonal tumours with multi-layered rosettes (ETMRs). Meagan’s HUG (Meagan Bebenek Foundation)
Dr. Xi Huang
Targeting potassium channel to disrupt the cellular hierarchy and suppress malignant growth of pediatric brain tumor. Canadian Institutes of Health Research
Targeting potassium channel in brain tumor- initiating cells. Sontag Foundation Distinguished Scientist Award
Canada Research Chair in Cancer Biophysics.
Canada Research Chair Program
Precision mechanical ablation of therapy-resistant brain tumor using magnetic carbon nanotubes. EMHSEED Interdivisional Research Funding Program
Establishing chloride intracellular channel CLIC1 as a therapeutic target for pediatric brain tumor. Canadian Institutes of Health Research
Treating the untreatable: Targeting pediatric brain tumors using multiple functional genomic models. SickKids Garron Family Cancer Centre
Bioelectrical signalling by ion channels in cell cycle. Natural Sciences and Engineering Research Council
Cellular and genetic heterogeneity as a therapeutic hurdle and opportunity for Ontarians with brain cancer. Ontario Institute for Cancer Research
Targeting potassium channel KCNN4 in FGFR3- TACC3 fusion gene-driven glioma. b.r.a.i.n.child
Defining the role of and mechanism by which the chloride channel CLIC1 regulates brain tumor growth. U.S. Department of Defense
Dr. Jane McGlade
Evaluation of TNIK protein kinase in Ph+ Leukemia. Pitblado Award, SickKids Garron Family Cancer Centre
Targeting alternative splicing in pediatric brain tumours. b.r.a.i.n.child
Ubiquitin system regulation of epithelial polarity.
Natural Sciences and Engineering Research Council of Canada
Approaches to regulate CBL ubiquitin ligase activity and control oncogenic tyrosine kinase signaling. Canadian Institutes of Health Research
3D-ORG: 3D screening infrastructure for tissue ORGanoids and model ORGanisms. Canada Foundation for Innovation
Infrastructure for the analysis of disease proteins.
Canada Foundation for Innovation
17